noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

.406 Ventures LLC

AI Frontier Models’ Potential Threats to SAP Systems Explored in Latest[...]
.406 Ventures LLC

Life After Cancer: Moving Beyond Your ‘New Normal’
AST Spacemobile Inc.

AST SpaceMobile Announces BlueBirds 11, 12, and 13 Orbital Launch in[...]

Healthcare

Myriad Genetics Inc.

06/23/2026 | Press release | Distributed by Public on 06/23/2026 06:32

Management Change/Compensation (Form 8-K)

ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On June 17, 2026, Daniel M. Skovronsky M.D., Ph.D., a member of the Board of Directors of Myriad Genetics, Inc. (the "Company") notified the Company that he is resigning as a director, effective immediately. Dr. Skovronsky's resignation was not a result of any disagreement with the Company or due to any matter relating to the Company's operations, policies, or practices.

Myriad Genetics Inc. published this content on June 23, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 23, 2026 at 12:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]